天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 584-08-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 584-08-7
Chemical Structure| 584-08-7
Structure of 584-08-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 584-08-7 ]

Related Doc. of [ 584-08-7 ]

Alternatived Products of [ 584-08-7 ]
Product Citations

Product Citations      Expand+

Qing Yun Li ; Leigh Anna Hunt ; Kalpani Hirunika Wijesinghe , et al. DOI:

Abstract: Strong photoinduced oxidants are important to organic synthesis and solar energy conversion, to chemical fuels or electric. For these applications, visible light absorption is important to solar energy conversion and long-lived excited states are needed to drive catalysis. With respect to these desirable qualities, a series of five 5,6-dicyano[2,1,3]benzothiadiazole (DCBT) dyes are examined as organic chromophores that can serve as strong photooxidants in catalytic systems. The series utilizes a DCBT core with aryl groups on the periphery with varying electron donation strengths relative to the core. The dyes are studied via both steady-state and transient absorption and emission studies. Additionally, computational analysis, voltammetry, crystallography, and absorption spectroelectrochemistry are also used to better understand the behavior of these dyes. Ultimately, a strong photooxidant is arrived at with an exceptionally long excited state lifetime for an organic chromophore of 16 μs. The long-lived excited state photosensitizer is well-suited for use in catalysis, and visible light driven photosensitized water oxidation is demonstrated using a water-soluble photosensitizer.

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; ; ; 51364-51-3 ; 538-75-0 ; 584-08-7 ; 1122-91-4 ; 123-30-8 ; 108-88-3 ; 109-77-3 ; 64-19-7 ; 603-35-0

Hintzsche, Samuel J. ; Vang, Zoua Pa ; Rivera Torres, Emanuel , et al. DOI: PubMed ID:

Abstract: Selective deuterium installation into small molecules is becoming increasingly desirable not only for the elucidation of mechanistic pathways and studying biological processes but also because of deuterium's ability to favorably adjust the pharmacokinetic parameters of bioactive molecules. Fused bicyclic moieties, especially those containing heteroatoms, are prevalent in drug discovery and pharmaceuticals. Herein, we report a copper-catalyzed transfer hydrodeuteration of cyclic and heterocyclic alkenes, which enables the synthesis of chromans, quinolinones, and tetrahydronaphthalenes that are precisely deuterated at the benzylic position. We also demonstrate the ability to place one deuterium atom at the homobenzylic site of these scaffolds with high regioselectivity by swapping transfer reagents for their isotopic analogs. Furthermore, examples of chemoselective transfer hydrogenation and transfer deuteration are disclosed, allowing for the simultaneous incorporation of two vicinal hydrogen or deuterium atoms into a double bond.

Keywords: copper ; deuteration ; hydrodeuteration ; hydrogenation ; transition metal catalysis

Purchased from AmBeed: ; ; ; ; ; ;

Product Details of [ 584-08-7 ]

CAS No. :584-08-7 MDL No. :MFCD00011382
Formula : K2CO3 Boiling Point : -
Linear Structure Formula :- InChI Key :BWHMMNNQKKPAPP-UHFFFAOYSA-L
M.W : 138.21 Pubchem ID :11430
Synonyms :
Chemical Name :Potassium carbonate

Calculated chemistry of [ 584-08-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 6
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 6.77
TPSA : 63.19 ?2

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.24 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : -0.13
Log Po/w (WLOGP) : -2.45
Log Po/w (MLOGP) : -1.6
Log Po/w (SILICOS-IT) : -0.44
Consensus Log Po/w : -0.92

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.61
Solubility : 33.5 mg/ml ; 0.243 mol/l
Class : Very soluble
Log S (Ali) : -0.74
Solubility : 25.0 mg/ml ; 0.181 mol/l
Class : Very soluble
Log S (SILICOS-IT) : 1.49
Solubility : 4260.0 mg/ml ; 30.8 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.25

Safety of [ 584-08-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P264-P270-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330-P501 UN#:N/A
Hazard Statements:H302-H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 584-08-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 584-08-7 ]
  • Downstream synthetic route of [ 584-08-7 ]

[ 584-08-7 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 1722-12-9 ]
  • [ 57260-73-8 ]
  • [ 584-08-7 ]
  • [ 137583-05-2 ]
Reference: [1] Patent: US6159964, 2000, A,
  • 2
  • [ 181955-94-2 ]
  • [ 584-08-7 ]
  • [ 7757-82-6 ]
  • [ 85817-34-1 ]
YieldReaction ConditionsOperation in experiment
78% With sodium cyanoborohydride; benzaldehyde; acetic acid In tetrahydrofuran; methanol 3.
4-Benzyl-2-hydroxymethylpiperazine
To a cooled (0° C.) and stirred solution of Intermediate 1 (22 g, 57 mmol), acetic acid (9.7 mL, 171 mmol) and sodium cyanoborohydride (7.16 g, 114 mmol) in methanol (440 mL) was added benzaldehyde (5.8 mL, 57 mmol).
The cooling bath was removed and the mixture stirred at room temperature for 3 h.
Saturated K2 CO3 solution (200 mL) was added and the mixture stirred for 15 min.
The solvents were evaporated and the residue partitioned between CH2 Cl2 (2*400 mL) and water (500 mL).
The combined organic layers were dried (Na2 SO4) and evaporated.
The residue was chromatographed on silica gel, eluding with CH2 Cl2: MeOH (95:5) to afford an inseparable mixture of 4-benzylpiperazine-2-carboxylic acid methyl ester and the corresponding ethyl ester (5.33 g, 40percent), in a 7:1 ratio respectively.
To a solution of the esters (5.33 g, 22.8 mmol) in THF (200 mL) was added LiAl H4 (22.8 mL of a 1.0M solution in ether) dropwise at -10° C.
Stirring was continued at -10° C. for 2.5 h.
After this time saturated Na2 SO4 solution (30 mL) was added and the cooling bath removed.
Stirring was continued at room temperature for 10 min then the mixture was filtered and the filtrate evaporated.
The residue was chromatographed on silica gel, eluding with CH2 Cl2:MeOH:NH3 (90:8:1-->60:8:1) to afford the title compound (3.7 g, 78percent) as a colourless oil. 1 H NMR (360 MHz, CDCl3) δ 1.89-1.95 (1H, m), 2.08-2.30 (3H, m), 2.68-2.71 (2H, m), 2.86-3.04 (3H, m), 3.45-3.60 (4H, m), 7.13-7.32 (5H, m). MS (ES+) 207 (M+1).
Reference: [1] Patent: US5849746, 1998, A,
  • 3
  • [ 57-55-6 ]
  • [ 584-08-7 ]
  • [ 16606-55-6 ]
Reference: [1] Patent: US6054596, 2000, A,
  • 4
  • [ 2457-50-3 ]
  • [ 7677-24-9 ]
  • [ 584-08-7 ]
  • [ 79-44-7 ]
  • [ 159307-02-5 ]
Reference: [1] Patent: US5350696, 1994, A,
[2] Patent: US5559214, 1996, A,
[3] Patent: US5760191, 1998, A,
Recommend Products
Same Skeleton Products
Historical Records
; ;